AMD Patients' knowledge gaps revealed in new study
NCT ID NCT03690505
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at what people with age-related macular degeneration (AMD) know about their disease and what they need to manage it better. Researchers will survey and interview 118 patients to understand their knowledge, daily challenges, and support needs. The goal is to use this information to create a patient education program that helps people take a more active role in their eye care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better educational programs that help AMD patients understand and manage their condition more effectively.
- What could go wrong
- This is an observational study with no treatment being tested, so it will not directly improve vision or slow the disease. The findings may not apply to all AMD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Ophtalmologie
Limoges, 87042, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can At-Home eye scans personalize wet AMD treatment?
- AI eye doctor: could a computer spot Blindness-Causing diseases faster than humans?
- Gene therapy injection aims to halt blinding eye disease
- Scientists track Long-Term safety of experimental AMD therapy
- Cheaper eye drug could save millions in AMD treatment costs
- New vision tests could speed up AMD treatment trials